The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of the PARP inhibitor (PI) ABT-888 (veliparib [vel]) either with carboplatin (carb) or as a single agent followed by post-progression therapy in combination with carb in patients (pts) with BRCA1- or BRCA2- (BRCA)-associated metastatic breast cancer (MBC).
 
George Somlo
Other Relationship - Abbvie
 
Paul Henry Frankel
No Relationships to Disclose
 
Thehang H. Luu
No Relationships to Disclose
 
Cynthia X. Ma
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Novartis
 
Banu Arun
Research Funding - Avon Foundation; NCI; NCI, Susan G. Komen, Avon; Susan G. Komen for the Cure
 
Agustin A. Garcia
Honoraria - Pfizer
Consulting or Advisory Role - Amgen; Novartis
 
Tessa Cigler
Honoraria - Novartis
Speakers' Bureau - Novartis
 
Leah Cream
No Relationships to Disclose
 
Harold A. Harvey
No Relationships to Disclose
 
Joseph A. Sparano
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Curis; Curis; Eisai; Genentech/Roche; Johnson & Johnson; Novartis; Sanofi
Research Funding - Merck (Inst)
 
Rita Nanda
No Relationships to Disclose
 
Helen K. Chew
No Relationships to Disclose
 
Timothy Jerome Moynihan
No Relationships to Disclose
 
Linda T. Vahdat
No Relationships to Disclose
 
Matthew P. Goetz
Consulting or Advisory Role - Lilly (Inst)
Travel, Accommodations, Expenses - Lilly
 
Arti Hurria
Consulting or Advisory Role - Boehringer Ingelheim; GTx; Seagen
Research Funding - Celgene (Inst); GlaxoSmithKline (Inst)
 
Joanne E. Mortimer
Honoraria - Novartis (I)
Consulting or Advisory Role - Puma Biotechnology
Speakers' Bureau - Novartis (I)
Research Funding - Cephalon; Novartis
Other Relationship - Novo Nordisk
 
David R. Gandara
Honoraria - Array BioPharma; AstraZeneca; Celgene; Lilly; Novartis; Synta
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Response Genetics; Sanofi; Synta
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); ImClone Systems (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biomarin; Boehringer Ingelheim; Dava Oncology; Pfizer
 
Alice P. Chen
No Relationships to Disclose
 
Jeffrey N. Weitzel
No Relationships to Disclose